Hasil Pencarian  ::  Simpan CSV :: Kembali

Abstrak :
Pendahuluan: C-reactive protein CRP dan procalcitonin PCT merupakan penanda diagnostik dan pemantauan sepsis neonatorum yang paling banyak digunakan. Saat ini terdapat penanda sepsis baru yaitu Soluble CD14 subtype sCD14-ST presepsin. Penelitian ini bertujuan untuk mengetahui manfaat pemeriksaan serial kadar presepsin, CRP dan PCT serta korelasi antara kadar presepsin dengan kadar CRP dan PCT sebagai penanda respons terapi dan prognosis pasien SNAL pada neonatus prematur. Metode: Desain penelitian kohort prospektif. Subjek penelitian terdiri dari 40 neonatus prematur sehat dan 40 pasien neonatus prematur SNAL dan dilakukan pemeriksaan kadar presepsin, CRP dan PCT, selanjutnya dilakukan pemantauan kadar presepsin, CRP dan PCT pasien neonatus prematur SNAL hari ke-3 dan ke-6 setelah diterapi. Pasien neonatus prematur SNAL dikelompokkan menjadi 20 pasien respons terapi dan 20 pasien non respons. Mortalitas pasien neonatus prematur SNAL ditentukan pada pemantauan hari ke-30. Hasil: Median kadar presepsin, CRP dan PCT pada neonatus prematur SNAL masing-masing adalah 1559 pg/mL 427 ndash; 4835 pg/mL, 16.35 mg/L 0.1 ndash; 245.6 dan 4.11 ng/mL 0.17 ndash; 54.18 lebih tinggi secara bermakna dibandingkan pada neonatus prematur sehat 406 pg/mL 195 ndash; 562 pg/mL, 1.22 mg/L 0.1 ndash; 3.69 dan 0.03 0.01 ndash; 0.04 dengan nilai p. ...... Introduction: C reactive protein CRP and procalcitonin PCT are marker of neonatal sepsis diagnostics and monitoring of the most widely used. Currently there is a new marker of sepsis that is Soluble CD14 subtype sCD14 ST presepsin. This study aims to determine the benefits of serial presepsin levels, CRP and PCT as well as the correlation between presepsin with CRP and PCT as a marker of response to therapy and prognosis of patients SNAL in premature neonates. Methods. This was prospective cohort, from 20 healthy preterm neonates and 40 LOS preterm neonates patient. The concentration of presepsin, CRP and PCT were analysed. Presepsin, CRP and PCT measured in both group and in 3rd 6th day sepsis follow up after therapy. Therapeutic respons was done in 20 LOS preterm neonates patient and 20 preterm neonates patient was not. The mortality of LOS preterm neonates patient saw in 30th day observation. Results: Median of presepsin, CRP and PCT in LOS preterm neonates are 1559 pg mL 427 ndash 4835 pg mL, 16.35 mg L 0.1 ndash 245.6 and 4.11 ng mL 0.17 ndash 54.18, respectively, are significantly higher than healty preterm neonates 406 pg mL 195 ndash 562 pg mL, 1.22 mg L 0.1 ndash 3.69 and 0.03 0.01 ndash 0.04, p value

Abstrak :
Latar belakang: Sepsis sulit dibedakan dengan respon inflamasi non infeksi secara klinis dan kultur darah yang merupakan gold standar diagnosis sepsis memiliki banyak keterbatasan. Presepsin merupakan suatu biomarker baru namun belum banyak data tentang efektifitas penggunaanya pada anak. Tujuan: Mengetahui nilai diagnostik dan prognostik presepsin dibandingkan dengan leukosit, PCT dan CRP pada pasien anak yang dicurigai sepsis ......Method: The latitude cut study was conducted during March-December 2020 at RSCM Jakarta on 56 patients aged 2 months - 10 years with suspicion of sepsis Diagnosis of sepsis is established based on the criteria of sepsis-3 and blood culture. Biomarker examination and PELOD-2 score are performed at the beginning and after 72 hours, mortality assessment is conducted on day 7. Presepsin levels are checked using the PATHFAST® method. Result: The median value of precessine levels in the proven sepsis group (1183 pg/ml was higher than that of the unproven group of sepsis (369 pg/ml, p=0.001). Precessine has a good diagnostic value (AUC of 0.862), with a cut of 711 pg/ml having a sensitivity of 75.8%, specificity of 82.6%, positive guess value of 86.2% and negative guess value of 70.4%, better than leukocytes, PCT, and CRP. Presepsin levels increased linearly with the severity of sepsis and were moderately correlated with PELOD-2 scores (r=0.548; p=0.001). Survival analysis showed precessine levels of ≥ 1,250 pg/ml were significantly associated with early mortality (HR 6.31; 95%CI; 1.67-23.83; p=0.007). Presepsin levels after 72 hours of antibiotic therapy decreased significantly in the improved sepsis group and increased in the worsening sepsis group. Inference: Presepsin is a reliable biomarker and can be used to help diagnose sepsis, predict severity, death and evaluate therapies in tertiary hospital services.

Abstrak :
ABSTRAK
Soluble CD14-ST presepsin merupakan penanda sepsis baru untuk diagnosis dan prognosis sepsis neonatorum. Kadar presepsin meningkat pada keadaan sepsis disebabkan oleh aktivitas protease di fagolisosom. Penelitian ini bertujuan untuk mengetahui manfaat pemeriksaan serial kadar presepsin sebagai penanda pemantauan respons terapi dan prognosis pada pasien SNAL secara bedside dengan menggunakan sampel darah kapiler. Desain penelitian kohort prospektif. Subjek penelitian terdiri dari 20 neonatus sehat dan 42 pasien SNAL. Pemeriksaan kadar presepsin dengan alat Pathfast pada hari ke-1, ke-3, dan ke-6 setelah diterapi. Kadar presepsin pada pasien SNAL 1104 pg/mL (608 ? 6225 pg/mL) lebih tinggi dibandingkan pada neonatus sehat 448 pg/mL (191 ? 513 pg/mL), nilai p 0,000. Pada pasien SNAL kelompok respons terapi kadar presepsin lebih rendah dibandingkan dengan kelompok non respons pada hari ke-3 dan ke-6 (p<0,05). Pada pasien SNAL kelompok non survivor kadar presepsin lebih tinggi dibandingkan dengan kelompok survivor hari ke-6 (p<0,05). Kadar presepsin berkorelasi positif dengan kadar CRP (r=0,488) dan jumlah leukosit (r=0,321). Nilai cut-off kadar presepsin hari ke-6 untuk penentuan prognosis 1365 pg/mL mempunyai AUC 0,789 (IK 95% 0,652 ? 0.926), sensitivitas 90.9%, dan spesifisitas 67,7%. Pemeriksaan presepsin hari ke-3 atau ke-6 secara bedside dengan darah kapiler bermanfaat untuk pemantauan terapi dan prognostik pasien SNAL.ABSTRACT
Soluble CD14-ST presepsin as a new septic marker for diagnostic and prognostic of neonatal sepsis. Concentration of presepsin significantly increases in bacterial sepsis induced by phagolysosome protease activity. The objective of this study is to investigate the prognostic and monitoring value of presepsin in late onset neonatal sepsis (LOS) with serial capillary whole blood assay. This was prosphective cohort, from 20 healthy neonates and 42 LOS patient. The concentration of presepsin was analysed using Pathfast analyzer at 1st, 3rd & 6th day after therapy. Median of presepsin in LOS patient is 1104 pg/mL (608 ? 6225 pg/mL) significantly higher than healty neonates 448 pg/mL (191 ? 513 pg/mL), p value 0.000. Median of presepsin at 3rd & 6th day after therapy in LOS with therapeutic respons is significantly lower than LOS with no respons (p<0.05). Median of presepsin at 6th day after therapy in nonsurvivor is significantly higher than in survivor (p<0.05). There are positive correlation between presepsin and CRP (r=0.488) or leucocyte count (r=0.321). Cut-off presepsin at 6th day after therapy 1365 pg/mL is found with AUC 0.789 (CI 95% 0.652 ? 0.926), sensitivity 90.9%, dan spesificity 67.7%. Presepsin assay at 3rd or 6th day after therapy with capillary whole blood can be used to predict the prognostic and therapeutic respons in LOS patient.;Soluble CD14-ST presepsin as a new septic marker for diagnostic and prognostic of neonatal sepsis. Concentration of presepsin significantly increases in bacterial sepsis induced by phagolysosome protease activity. The objective of this study is to investigate the prognostic and monitoring value of presepsin in late onset neonatal sepsis (LOS) with serial capillary whole blood assay. This was prosphective cohort, from 20 healthy neonates and 42 LOS patient. The concentration of presepsin was analysed using Pathfast analyzer at 1st, 3rd & 6th day after therapy. Median of presepsin in LOS patient is 1104 pg/mL (608 ? 6225 pg/mL) significantly higher than healty neonates 448 pg/mL (191 ? 513 pg/mL), p value 0.000. Median of presepsin at 3rd & 6th day after therapy in LOS with therapeutic respons is significantly lower than LOS with no respons (p<0.05). Median of presepsin at 6th day after therapy in nonsurvivor is significantly higher than in survivor (p<0.05). There are positive correlation between presepsin and CRP (r=0.488) or leucocyte count (r=0.321). Cut-off presepsin at 6th day after therapy 1365 pg/mL is found with AUC 0.789 (CI 95% 0.652 ? 0.926), sensitivity 90.9%, dan spesificity 67.7%. Presepsin assay at 3rd or 6th day after therapy with capillary whole blood can be used to predict the prognostic and therapeutic respons in LOS patient.;Soluble CD14-ST presepsin as a new septic marker for diagnostic and prognostic of neonatal sepsis. Concentration of presepsin significantly increases in bacterial sepsis induced by phagolysosome protease activity. The objective of this study is to investigate the prognostic and monitoring value of presepsin in late onset neonatal sepsis (LOS) with serial capillary whole blood assay. This was prosphective cohort, from 20 healthy neonates and 42 LOS patient. The concentration of presepsin was analysed using Pathfast analyzer at 1st, 3rd & 6th day after therapy. Median of presepsin in LOS patient is 1104 pg/mL (608 ? 6225 pg/mL) significantly higher than healty neonates 448 pg/mL (191 ? 513 pg/mL), p value 0.000. Median of presepsin at 3rd & 6th day after therapy in LOS with therapeutic respons is significantly lower than LOS with no respons (p<0.05). Median of presepsin at 6th day after therapy in nonsurvivor is significantly higher than in survivor (p<0.05). There are positive correlation between presepsin and CRP (r=0.488) or leucocyte count (r=0.321). Cut-off presepsin at 6th day after therapy 1365 pg/mL is found with AUC 0.789 (CI 95% 0.652 ? 0.926), sensitivity 90.9%, dan spesificity 67.7%. Presepsin assay at 3rd or 6th day after therapy with capillary whole blood can be used to predict the prognostic and therapeutic respons in LOS patient.;Soluble CD14-ST presepsin as a new septic marker for diagnostic and prognostic of neonatal sepsis. Concentration of presepsin significantly increases in bacterial sepsis induced by phagolysosome protease activity. The objective of this study is to investigate the prognostic and monitoring value of presepsin in late onset neonatal sepsis (LOS) with serial capillary whole blood assay. This was prosphective cohort, from 20 healthy neonates and 42 LOS patient. The concentration of presepsin was analysed using Pathfast analyzer at 1st, 3rd & 6th day after therapy. Median of presepsin in LOS patient is 1104 pg/mL (608 ? 6225 pg/mL) significantly higher than healty neonates 448 pg/mL (191 ? 513 pg/mL), p value 0.000. Median of presepsin at 3rd & 6th day after therapy in LOS with therapeutic respons is significantly lower than LOS with no respons (p<0.05). Median of presepsin at 6th day after therapy in nonsurvivor is significantly higher than in survivor (p<0.05). There are positive correlation between presepsin and CRP (r=0.488) or leucocyte count (r=0.321). Cut-off presepsin at 6th day after therapy 1365 pg/mL is found with AUC 0.789 (CI 95% 0.652 ? 0.926), sensitivity 90.9%, dan spesificity 67.7%. Presepsin assay at 3rd or 6th day after therapy with capillary whole blood can be used to predict the prognostic and therapeutic respons in LOS patient.

Abstrak :
Latar belakang: Sepsis pascabedah jantung terbuka merupakan kondisi yang jarang terjadi tetapi memiliki mortalitas yang cukup tinggi. Gejala sepsis yang muncul pascabedah seringkali sulit dibedakan dengan kondisi inflamasi sistemik sehingga menimbulkan keterlambatan dalam menegakkan diagnosis maupun overtreatment pada pasien. Presepsin merupakan salah satu penanda sepsis yang mulai banyak digunakan terutama pada populasi dewasa. Penelitian ini bertujuan untuk melihat peran presepsin dalam menegakkan diagnosis sepsis pascabedah jantung terbuka pada anak. Tujuan: Untuk menguji performa diagnostik presepsin sebagai penanda sepsis pada anak pascabedahjantung terbuka dibandingkan dengan prokalsitonin (PCT). Metode: Studi potong lintang terhadap 49 pasien anak pascabedah jantung terbuka yang dirawat di RSCM. Penelitian ini mencari nilai batas optimal presepsin untuk mendiagnosis sepsis pascabedah jantung terbuka pada anak yaitu pada hari pertama dan ketiga pascabedah, kemudian membandingkannya dengan prokalsitonin. Analisis kurva ROC dikerjakan untuk menentukan nilai batas optimal presepsin. Hasil: Kadar presepsin hari pertama (T1) dan ketiga (T3) lebih tinggi pada subyek dengan sepsis daripada subyek yang tidak sepsis (median 415 pg/mL vs. 141,5 pg/mL pada hari pertama dan 624 pg/mL vs. 75,9 pg/mL pada hari ke tiga). Titik potong presepsin pada T1 dengan nilai 404 pg/mL memiliki performa untuk mendiagnosis sepsis dengan AUC 0,752 sedangkan presepsin T3 dengan nilai 203,5 pg/mL dengan AUC 0,945 yang lebih baik dibandingkan T1. Simpulan: Presepsin dapat dijadikan suatu modalitas untuk memberikan nilai tambah dan pertimbangan bagi klinisi untuk menegakkan diagnosis sepsis pada pasien anak pascabedah jantung terbuka. ......Background: Postoperative open-heart sepsis is a rare condition but has a fairly high mortality. Symptoms of sepsis that appear postoperatively are often difficult to distinguish from systemic inflammatory conditions, causing delays in establishing diagnosis and overtreatment in patients. Presepsin is one of the markers of sepsis that is starting to be widely used, especially in the adult population. This study is to identify the role of presepsin for diagnosing sepsis in post open-heart surgery in pediatric population. Aim: To perform diagnostic test of presepsin as sepsis screening markers compares to procalcitonin (PCT) in post open-heart surgery. Methods: Cross-sectional study of 49 postoperative open-heart pediatric patients treated at RSCM. This study looked for optimal cut-off values of presepsin for diagnosing open-heart postoperative sepsis in children on the first and third postoperative days, then compared it with procalcitonin. ROC curve analysis is performed to determine the optimal limit value of presepsin. Result: First (T1) and third day (T3) PSP levels were higher in subjects with sepsis than non- sepsis (median 415 pg/mL vs. 141.5 pg/mL on first day and 624 pg/mL vs. 75.9 pg/mL on third day). ). T1 presepsin cut off 404 pg/ml had AUC of 0.772, while T3 presepsin cut off 203.5 og/ml had better AUC of 0.945. T3 is better for diagnosing sepsis. Conclusion: Presepsin can be used as a modality to provide added value and consideration for clinicians to establish the diagnosis of sepsis in pediatric patients after open-heart surgery.

Abstrak :
Prevalens SNAD NKB < 34 minggu dan atau BLSR di Indonesia masih tinggi. Asuhan antenatal yang tidak adekuat, gejala infeksi saat lahir yang sulit dibedakan dengan prematuritas, dan modalitas diagnostik yang suboptimal membuat diagnosis SNAD pada populasi ini sulit. Presepsin salah satu marker infeksi meningkat saat awal infeksi berpotensi dijadikan salah satu parameter diagnostik SNAD. Tujuan penelitian ini adalah untuk melihat akurasi presepsin sebagai salah satu parameter diagnosis SNAD dan dibandingkan dengan CRP. Studi ini merupakan studi potong lintang terhadap 71 NKB < 34 minggu dan atau BLSR dengan faktor risiko SNAD lebih tinggi atau faktor risiko SNAD rendah yang menunjukkan gejala sepsis di Unit Perinatologi RSCM. Penelitian ini mencari nilai batas presepsin sebagai parameter diagnostik SNAD pada berbagai waktu pengambilan, kemudian membandingkannya dengan CRP. Kurva ROC dikerjakan untuk menentukan nilai batasan optimal presepsin. Penelitian ini mendapat nilai presepsin lebih tinggi pada kelompok SNAD dibandingkan dengan non-sepsis (median 814, 802, dan 693 pg/mL, p<0,05). Presepsin mencapai nilai puncaknya pada T1 sedangkan CRP pada T24. Nilai batas optimal, batas bawah dan batas atas presepsin T1 adalah 621,5, 458, 808 pg/mL. Pada T4 yaitu 733, 518,5, 733 pg/mL serta T24 yaitu 667,5, 556,5, 820,5 pg/mL. Nilai batas presepsin T1 memiliki sensitivitas 82,14%, spesifisitas 81,4%, NDP 74,19%, NDN 87,5%, dan akurasi 81,69%. Sedangkan presepsin T4 memiliki sensitivitas 60,71%, spesifisitas 93,02%, NDP 85%, NDN 78,43% dan akurasi 80,28%. Nilai batasan presepsin T24 memiliki sensitivitas 64%, spesifisitas 86%, NDP 75% dan NDN 78,7% dan akurasi 77,46%. Sebagai kesimpulan, presepsin meningkat sesaat setelah lahir jika terjadi infeksi. Presepsin T1 dapat digunakan sebagai parameter skrining SNAD dengan menggunakan nilai batasan optimal 621,5 pg/mL. Presepsin dengan berbagai nilai batasan tertentu memiliki fungsi yang berbeda dan dapat diaplikasikan ke dalam alur diagnosis dan tata laksana SNAD berdasarkan faktor risiko populasi tersebut. ......Early onset neonatal sepsis prevalence in Indonesia remains high among preterm neonates born at <34 weeks' gestation and or VLBW. Inadequate antenatal care, infectious symptoms at birth that are confusing to distinguish from prematurity, and poor predictive performance of laboratory tests made diagnosis of EOS is wearisome. Presepsin, one of the biomarkers, increases early in onset of infection has potential to become diagnostic tools for EOS. The objective of this study is to find the accuracy of presepsin as one of EOS diagnostic tools and compared it with CRP. This study is a cross-sectional study of of 71 neonates born at < 34 weeks' gestation and or VLBW at higher risk of EOS or at lower risk for EOS that showing some degree of respiratory or systemic instability. Presepsin which was collected in different time interval (T1, T4 and T24), compared to diagnostic criteria of sepsis as the gold standard. The accuracy of CRP with currently cut-off points also analyzed in this study. The ROC curve was performed to determine the optimal cut-off points of presepsin. Presepsin values were higher in the EOS group than in uninfected group at T1(median 814 vs 438 pg/mL; p<0.05) T4 (802 vs 445 pg/mL; p<0.05), and T24 (693 vs 469 pg/ mL; p <0.05). Presepsin achieved best accuracy at T1 and reaches its peak value at T1 while CRP have it at T24. Optimal cut-off points, the lower limit and the upper limit of presepsin at T1 are 621.5, 458, 808 pg/mL. At T4 are 733, 518.5, 733 pg/mL and T24 are 667.5, 556.5, 820.5 pg/mL. With those optimal cut-off value, presepsin has 82.14% sensitivity, 81.4% specificity, 74.19% PPV, 87.5% NPV, and accuracy of 81.69%. Whereas presepsin at T4 has 60.71% sensitivity, 93.02% specificity, 85% PPV, 78.43% NPV and an accuracy of 80.28%. Presepsin at T24 has a sensitivity of 64%, a specificity of 86%, an NDP of 75% and an NDN of 78.7% and an accuracy of 77.46%. In conclusion, presepsin increases shortly after birth in EOS group. Presepsin at T1 can be used as EOS screening tools by using an optimal cut-off value of 621.5 pg/mL. Presepsin with certain boundary values have different functions and perhaps can be applied to the EOS diagnosis and management pathways in RSCM.